Objective: The outcomes of carotid angioplasty and stenting (CAS) are, in addition to patient baseline characteristics, highly dependent on the safety of the endovascular procedure. During the successive stages of CAS, transcranial Doppler (TCD) monitoring of the middle cerebral artery was used to assess the association of cerebral embolism and hemodynamic changes with transient (amaurosis fugax and transient ischemic attack) and persistent (minor and major stroke) cerebral deficits, and death. Methods: By use of a prospectively completed database of 550 patients, the association of various TCD emboli and velocity variables with periprocedural cerebral outcome <7 days was evaluated by univariable and multivariable logistic regression analyses in combination with receiver operating characteristic (ROC) curve analyses. The impact of basic patient characteristics, such as age, sex, preprocedural cerebral symptoms, and ipsilateral carotid endarterectomy before CAS was also evaluated. Carotid endarterectomy (CEA) has been used to treat atherosclerotic carotid bifurcation disease for Ͼ50 years. Over this period of time, the surgical technique has undergone minor modifications and the indications for repair have been refined. This operation has held up to the scrutiny of several large multicenter randomized trials, 1-4 and more CEAs are currently being performed than at any time in the history of this operation.
Carotid endarterectomy (CEA) has been used to treat atherosclerotic carotid bifurcation disease for Ͼ50 years. Over this period of time, the surgical technique has undergone minor modifications and the indications for repair have been refined. This operation has held up to the scrutiny of several large multicenter randomized trials, [1] [2] [3] [4] and more CEAs are currently being performed than at any time in the history of this operation.
In terms of both safety and efficacy, carotid artery stenting (CAS) has emerged as a potential alternative to CEA in the last few years. Potential advantages of CAS over CEA include avoidance of neck wound complications and nerve injuries and an ability to treat surgically inaccessible lesions such as high internal carotid artery (ICA) stenoses. The main hazard of CAS is that atherosclerotic material dislodged during the procedure may embolize to the cerebral circulation and result in cerebral ischemia. Moreover, extensive manipulation in the vicinity of the carotid sinus leads to an increased parasympathetic discharge and a reduction of systematic arterial smooth muscle tone that can result in hypotension and bradycardia.
As a result of recent developments in transcranial Doppler (TCD) monitoring, not only can blood flow velocities in the middle cerebral artery (MCA) be monitored, but microemboli can also be detected. For example, its role of evaluating the impact of cerebral microemboli on brain function in coronary artery bypass grafting 5, 6 is increasing, and perioperative TCD monitoring can be used to evaluate the pathogenesis of stroke complicating CEA. 7 We have previously reported our experience with TCD monitoring and its usefulness with regard to emboli detection in CAS. 8, 9 However, these studies were primarily designed to test the pattern of microembolic phenomena during various stages of the endovascular procedure and to verify whether the use of filtering emboli protection devices resulted in a decrease of the cerebral embolic load.
In the present study, we analyzed in a multivariable logistic regression model which TCD-detected emboli variables were associated with the occurrence of operative cerebral complications (transient and persistent) and death Յ7 days after the procedure. In that regression model, we also included intraoperative velocity variables and some baseline patient characteristics. Identification of predictors of outcome in CAS can be useful in understanding the pathophysiologic mechanisms of cerebral complications and may help to stratify patients according to their risk of periprocedural stroke.
METHODS

Patients.
The methods of our study are described elsewhere. 7, 8 In brief, data from all patients who underwent CAS of the carotid bifurcation in our institution from December 1997 through April 2004 were analyzed and include 550 consecutive patients. Data were prospectively entered into a database. Patients were excluded from CAS in case of peripheral vascular or aortic arch disease sufficiently severe to prevent adequate vascular access, severe renal insufficiency, and severe disability due to previous stroke or dementia. Patients who underwent angioplasty with stent placement at the origin of the common carotid artery were excluded from the present analysis. In patients who underwent a second procedure (ipsilaterally or contralaterally), only the first was included in the analysis, leaving 550 analyzable procedures.
The risks and benefits of CAS compared with CEA were reviewed in detail with each patient before proceeding with CAS, and this review was approved by the institutional review board. The endovascular procedures were done by interventional cardiologists or radiologists, respectively.
Most patients (361, 66%) were neurologically asymptomatic, 189 patients (34%) had retinal or cerebral symptoms of amaurosis fugax (Afx), transient ischemic attack (TIA), or minor stroke before treatment. In 385 patients (70%), CAS was performed before coronary artery bypass grafting, valve replacement, or reconstructive aortic surgery. These and other baseline characteristics such as age, gender, and prior ipsilateral CEA were recorded (Table I) . According to the North American Symptomatic Carotid Carotid angioplasty and stenting. All patients took aspirin (100 mg/d) and clopidogrel (75 mg/d) starting 3 days before the procedure. An intravenous bolus of 5,000 to 10,000 units of heparin was administered before sheath insertion; 0.5 to 1.0 mg of atropine was administered intravenously before predilation, poststent dilation, or both, to prevent bradycardia during balloon inflation. Patients were treated under local anesthesia from a femoral approach. If necessary, a predilation was performed with a 2.5-to 3.5-mm balloon, followed by introduction of a self-expandable stent. Postdilation after stent deployment was performed with a balloon size between 5 and 8 mm, depending on the diameter of the ICA as determined by preprocedural duplex scanning and intra-arterial digital subtraction angiography.
A filtering cerebral emboli protection device was used in 181 procedures (33%): the FilterWire (Boston Scientific, Natick, Mass) was used in 130 patients, the AngioGuard (Cordis, Minneapolis, Minn) in 27, and a variety of filters were used in the remaining 24 patients. The use of a filter wire protection device was at the discretion of the interventionist and selected by availability. Balloon protection was not evaluated in this study. Lesion morphology and severity of stenosis on screening duplex scans and diagnostic arteriograms were not used as selection criteria for embolic protection. The filter was introduced before stent placement, and whenever possible, before predilation. It was either removed after postdilation or postprocedural arteriography.
Transcranial Doppler monitoring. The methods of TCD monitoring during CAS have been described elsewhere. 8 In addition to hemodynamic changes during balloon inflation at predilation and postdilation, the present study had a special interest in the occurrence of isolated microemboli according to the criteria described by the consensus committee. 10 The embolic signals that particularly occur during balloon deflation and stent deployment could not be counted individually, so the number of heart beats with showers of microemboli were counted. A macroembolus was defined as an embolus that partially or completely obstructed the MCA main stem for a period of several seconds to minutes.
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The Doppler spectra were observed in the angiography suite by an experienced sonographer, and the audio Doppler signal was made audible throughout the entire procedure. Moreover, for off-line analysis, the Doppler signals were continuously recorded on digital audiotape.
Emboli were counted in each stage of the procedure without the use of automated emboli detection software. During the passage of the angiographic contrast medium, a wide and high increase in Doppler signal intensity that confused microemboli detection was often observed in the MCA. Therefore, signals that occurred during these phases of the procedure were excluded from the analysis.
TCD emboli and velocity variables. From our previous research on TCD monitoring during CAS, 8, 9 the following TCD emboli variables (isolated and showers) were thought to be associated with adverse cerebral outcome: (1) at predilation before stent placement, (2) at stent deployment, (3) at postdilation after stent placement, and (4) during introduction and removal of a filter protection device. Also evaluated for their impact on outcome were particulate macroembolism, massive air embolism during balloon rupture, and angioplasty-induced asystole of Ͼ15 seconds with significant hypotension (Ͻ80 mm Hg) in combination with a Ͼ70% reduction in MCA mean blood flow velocity.
Preoperative patient and procedure related characteristics. Age, sex, preoperative cerebral and retinal symptoms, and ipsilateral CEA before stent placement were also documented. Prior research 9 showed that use of a filter wire cerebral emboli protection device resulted in significantly more TCD-detected microemboli (isolated as well as showers) in all three stages (predilation, stent deployment, and postdilation) of protected procedures compared with nonprotected procedures. Therefore, the impact of the use of a filter on cerebral outcome was also evaluated.
Clinical outcome. All patients were formally assessed before and after the procedure by a neurologist who was not involved in the intervention. During CAS, a different neurologist was present in the angiography suite. Patients held a rubber squeak toy in the contralateral hand and were instructed to squeeze if symptoms developed.
New cerebral deficits persisting for Ͼ24 hours were regarded as stroke, the severity of which was graded according to the modified Rankin scale. 12 Major strokes Ͼ3 on the Rankin scale, while minor stroke did not. Procedurerelated deficit was defined per patient and not per procedure. In patients with adverse cerebral outcome, computed tomography or magnetic resonance imaging of the brain was performed. In the analyses, we focused on the prediction of transient cerebral deficits (Afx and TIA), minor and major strokes (ischemic and hemorrhagic), and death Յ7 days after the procedure.
Statistical analysis. First, the association between adverse cerebral outcome (Afx, TIA, stroke or death) and each of the previously mentioned TCD variables and preoperative patient characteristics was quantified by use of univariable logistic regression analysis. The odds ratio (OR) and 95% confidence interval (CI) were used as measures of association. A variable with a 95% CI that does not include the value 1 can be considered statistically significantly associated with a P Ͻ .05. Continuous variables were initially included without categorization as long as a relation was plausible, but various cutoff values and transformations were assessed as well. 13 The TCD microemboli variables (isolated and showers) were dichotomized at clinically relevant thresholds on the basis of previous results 8 or marked differences in the actual incidence of adverse cerebral outcome. Finally, the number of TCD variable showers of microemboli at postdilation after stent placement was dichotomized by selecting that number of showers that showed the highest likelihood ratio (sensitivity/1 -specificity) in predicting adverse cerebral outcome.
The calculated probability by logistic regression is used as a continuous variable, and for each cutoff value of the TCD variable, the sensitivity and specificity are determined and graphically depicted as a receiver operating characteristic (ROC) curve. This is a statistically orientated choice of the optimal predicting value compared with a choice based on clinically relevant thresholds.
Our aim was not to develop a prediction model primarily based on preoperative clinical characteristics but to assess whether and which TCD variables were associated with adverse cerebral outcome. Accordingly, we estimated which of the TCD variables was independently associated with outcome by use of multivariable logistic regression modelling. The aim of this analysis was the prediction of adverse cerebral outcome, and so all possible variables contributing prognostic information should be included in the model (step-by-step or block-by-block). Therefore, as is common in prediction research, we defined a useful association if the OR had a significance level of P Յ .10, and the nonsignificant (P Ͼ.10) variables were excluded.
The first model included only the two variables of dichotomized showers of microemboli at postdilation after stent placement and angioplasty-induced asystole of Ͼ15 seconds with significant hypotension (Ͻ80 mm Hg) in combination with a Ͼ70% reduction in MCA mean blood flow velocity. This model was extended with the additional univariate significant TCD variables (particulate macroembolus and massive air embolism), and it was assessed whether the OR and 95% CI in this extended model did not exclude the value 1. Finally, a last model was defined that was extended with the preoperative patient characteristic that was significant (P Յ .10) in the univariable analyses (preprocedural cerebral ischemia), resulting in the final model.
For each model, the ability to discriminate between patients with and without complications was estimated by using the area under the ROC curve. The ROC area is a suitable parameter to summarize the predictive or discriminative ability of a model and can range from 0.5 (useless model, such as a coin flip) to 1.0 (perfect discrimination). A value Ͼ0.7 can be interpreted as reasonable, and a value Ͼ0.8 can be interpreted as good. Differences in discriminative value between models were estimated by differences in ROC area with 95% CI, taking into account the correlation between models because they were based on the same cases. Table I lists the distribution of baseline patient characteristics, TCD emboli and velocity variables, and outcome. Female patients were older than male patients (mean age, 73 vs 69 years, P ϭ .001). Fifty-three patients (9.6%) had ipsilateral CEA prior to CAS. The composite morbidity and mortality, which includes Afx, retinal infarct, TIA, minor and major strokes, and death, was 11.5% (63/550). One patient had a retinal infarct with persistent partial blindness of the ipsilateral eye, and 36 patients (6.5%) showed transient retinal (Afx, 6; 1.1%) or cerebral (TIA, 30; 5.4%) deficits during the procedure or Յ7 days after. Fifteen patients (2.7%) had a minor stroke, 6 (1.1%) had a major stroke, and 5 patients (0.9%) died. The cumulative rate of minor and major stroke and death was 4.7% (26/550).
RESULTS
In 84 patients (15.8%) with inadequate temporal windows, TCD monitoring of blood flow velocities in the ipsilateral MCA was not possible. In 15 procedures (2.7%). no angioplasty or stent placement was performed. The procedure was discontinued in 11 cases because of technical or anatomic impediments, in 2 cases because the stenosis was less severe than anticipated, and in 1 case because the ICA had asymptomatically become occluded in the days between the last preprocedural duplex scan and the procedure. A major stroke occurred in one patient during arteriography before CAS. This patient did not receive a stent, but was included in the present analysis. In three additional patients (0.5%), poststenting angioplasty was not performed. Of the remaining 448 procedures, 125 (29%) showed more than five showers of microemboli at postdilation after stent deployment. Particulate macroembolism and massive air embolism at balloon rupture were noticed in eight and five procedures, respectively. Finally, angioplasty-induced asystole of Ͼ15 seconds with significant hypotension (Ͻ80 mm Hg) plus Ͼ70% reduction in MCA mean blood flow velocity occurred in 22 procedures (4%).
Showers of microemboli at postdilation showed a significant association with adverse cerebral outcome (Table II) . After dichotomization, the TCD emboli variable of more than five showers of microemboli at postdilation showed a significant association with adverse cerebral outcome (P ϭ .003). The three additional TCD variables of particulate macroembolus, massive air embolism, and severe asystole with hypotension also showed a statistically significant association with outcome. The 95% CIs of these variables were wide, however. Table II also delineates that the use of a cerebral emboli filter wire device did not result in a statistically significantly lower number of adverse cerebral events (P ϭ .7). Of the patient characteristics, only preprocedural cerebral ischemia was associated with an increased risk of adverse outcome. Age (whether analyzed as a continuous or as a dichotomous variable with a cutoff of 75 years), sex, and prior ipsilateral CEA were statistically nonsignificant predictors.
The model, including showers of microemboli at postdilation and significant asystole and hypotension, is given in Table III (model 1) . The ROC area of this model was 0.64. After adding the two additional TCD variables (particulate macroemboli and massive air embolism) to model 1, all four TCD variables were associated with outcome (model 2, Table III ). The ROC area increased to 0.72.
Model 2 was subsequently extended with the only univariably significant preprocedural patient characteristic (preprocedural cerebral ischemia). This resulted in a ROC JOURNAL OF VASCULAR SURGERY Volume 41, Number 4 area of 0.80 (model 3, Table III ). In this last model, all variables remained associated with adverse cerebral outcome. In the present analysis, the use of a filter protection device did not show a statistically significant association with cerebral outcome (Table II , P ϭ .7), and, therefore, this variable was not incorporated in our modeling.
DISCUSSION
In the present study we evaluated which TCD monitoring variables were independently associated with early adverse cerebral outcome and death from CAS. We found that of all TCD microemboli variables quantified during the various stages of CAS, only the variable "more than 5 showers of microemboli at postdilation after stent deployment" was associated with transient and persistent retinal and cerebral deficits Յ7 days. This association remained after taking into account three additional TCD emboli and velocity variables and various patient characteristics. The TCD emboli variables "macroembolus" and "massive air embolism" were associated with outcome independent from the TCD velocity variable (Ͼ70% reduction of MCA blood flow velocity during angioplasty-induced asystole with significant hypotension) and the patient characteristic "preprocedural cerebral ischemia."
Our results should be placed in the context with other reports on TCD monitoring during CAS.
14-21 However, most of these studies described a small number of patients, often featuring only balloon angioplasty without stent placement. Moreover, isolated microemboli were not clearly separated from showers of microemboli, and macroemboli were not differentiated.
The present study is an expansion of a previous research from our group 8 by almost doubling the number of patients analyzed. In this perspective, it is important to underline that in the former study, the variable "multiple showers at postdilation after stent placement" only showed a statistically significant association with intraprocedural adverse cerebral outcome. Although in the present enlarged study one third (21/63) of the cerebral events occurred with a symptom-free interval after the procedure, the variable "more than five showers of microemboli at postdilation after stent placement" now also showed a statistically significant association with adverse outcome Յ7 days. In addition to clear adverse events such as macroembolism and massive air embolism, microemboli that occur at postdilation after stent deployment are a major and independent risk factor for periprocedural cerebral deficit. Obviously, an uncovered stent squeezes plaque material from the vessel wall through the stent mesh that subsequently contributes to embolization in the cerebral circulation.
Various protection strategies have been introduced to minimize the risk of these embolic events, and in the present study, a filter wire protection device was used in one third of the procedures (181/550). However, former research from our institution 9 on the impact of filtering protection devices on the cerebral embolic load showed that in all three stages of the stenting procedure (predilation, stent deployment, and postdilation), the number of TCD detected microemboli was significantly higher in protected than in nonprotected procedures. This resulted in a changing belief in the usefulness of filter protection between the two groups involved in CAS: cardiologists decided to use filters as much as possible; in contrast, radiologists now use filters as little as possible. In the present study, however, use of cerebral filter protection increased from 0% during the first 2 years to 66% during the last 2 years.
As documented by others, [21] [22] [23] we also found that transient, moderate hypotension occurs frequently during and after CAS and resolves spontaneously in most patients. Although most of these events can be considered benign and self-limiting, hemodynamic instability due to asystole and severe hypotension may complicate CAS. In the present study, asystole resulted in severe hypotension in 4% (22/550), with a significant reduction of MCA blood flow velocities, and this was related with adverse cerebral outcome in seven of these 22 patients. Most of these cases occurred during the the first years of our study period. Undoubtedly, more aggressive use of vasopressor agents, adequate fluid balance, and advances in technique and equipment made the procedure safer in the subsequent years.
It was not our intention to develop a prediction model primarily based on preoperative clinical and angiographic predictors of adverse cerebral outcome from CAS. Nevertheless, besides the above-mentioned procedure-related variables, preprocedural cerebral ischemia was significantly associated with outcome. Actually, symptomatic patients were about four times more likely to have an adverse cerebral outcome (transient and persistent) during CAS than asymptomatic patients. In CEA, Rothwell et al 24, 25 showed that in addition to age, female sex, hypertension, and peripheral vascular disease, preoperative cerebral symptoms were also a predictor of stroke. Age, gender, and prior ipsilateral CEA were not associated with cerebral outcome in the present study on CAS.
To appreciate the present results, a few aspects need to be discussed. First, in contrast with other studies that evaluated the association of preprocedural patient characteristics with cerebral outcome from CAS, 26 we evaluated whether clinically relevant intraprocedural TCD emboli and velocity variables were associated with adverse cerebral outcome, taking into account some always available basic patient characteristics.
Second, the analysis includes data from the first years of CAS; thus, the presence of a learning effect will be likely. Particularly with respect to hemodynamic instability and the use of emboli filter wire devices, in the course of time, interventionists developed an understanding of and reliance on the TCD data.
Third, TCD gives no information about the composition of the microemboli. Because we excluded from our analyses the time during which contrast passed through the MCA during arteriography, almost all of the microemboli probably were particulate. Significant air embolism was only noticed after balloon rupture. Moreover, no emboli detection software was used.
Fourth, although the TCD variables "particulate macroembolus" and "massive air embolism" were independently associated with outcome, the 95% CIs of the predictions were wide. In other words, the precision of these measurements was not high because of the relatively small number of procedures during which these events happened.
Fifth, to increase the power of our regression modeling, we used TIA and Afx as clinical end points in addition to stroke. Probably, these so-called soft end points show pathophysiologically the same mechanisms as clinically more important end points such as minor and major stroke. They are therefore useful in a preliminary prediction model, and further research has to prove whether significant cerebral embolic load at postdilation also shows a negative impact on periprocedural stroke.
Finally, because 70% of our patients underwent major surgery within 3 to 4 weeks after CAS, we limited the perioperative morbidity and mortality assessment to the in-hospital (Յ7 days) period. Certainly, the 30-day complication rates for CAS and for heart or aortic surgery, or both, will be somewhat higher.
In conclusion, we have determined that in addition to obviously adverse events such as macroembolism and massive air embolism, multiple (Ͼ5) microembolic showers that occur at balloon deflation during postdilation after stent deployment, and angioplasty-induced asystole with hypotension and significant reduction of MCA blood flow velocities were associated with periprocedural cerebral outcome. To our knowledge, the association with cerebral deficits has not been demonstrated before, certainly not by using a multivariable approach that takes into account some basic preoperative patient characteristics. We believe this is relevant information that can be used to guide further development of cerebral protection devices. Our data also demonstrate that in CAS, the risk of an adverse cerebral event is significantly higher in symptomatic than in asymptomatic patients.
